Medical Marijuana in the Workplace Challenges and Management Options for Occupational Physicians

被引:30
作者
Goldsmith, Robert S. [1 ]
Targino, Marcelo C. [2 ]
Fanciullo, Gilbert J. [3 ]
Martin, Douglas W. [4 ]
Hartenbaum, Natalie P. [5 ]
White, Jeremy M. [6 ]
Franklin, Phillip [7 ]
机构
[1] Novartis Pharmaceut, E Hanover, NJ 07936 USA
[2] Johnson & Johnson, New Brunswick, NJ USA
[3] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03766 USA
[4] UnityPoint Hlth St Lukes, Occupat Med, Sioux City, IA USA
[5] Occumedix Inc, Dresher, PA USA
[6] Kaye Scholer LLP, Washington, DC USA
[7] Bayer Corp, Asbury Pk, NJ USA
关键词
ORAL DELTA(9)-TETRAHYDROCANNABINOL; SMOKED MARIJUANA; CANNABIS; PERFORMANCE; DELTA-9-TETRAHYDROCANNABINOL; PHARMACOKINETICS; METABOLISM; SMOKING;
D O I
10.1097/JOM.0000000000000454
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although possession and use of marijuana is prohibited by federal law, legalization in four states (Alaska, Colorado, Oregon, and Washington) and allowance for palliation and therapy in 19 others may reposition the drug away from the fringes of society. This evolving legal environment, and growing scientific evidence of its effectiveness for select health conditions, requires assessment of the safety and appropriateness of marijuana within the American workforce. Although studies have suggested that marijuana may be used with reasonable safety in some controlled environments, there are potential consequences to its use that necessitate employer scrutiny and concern. Several drug characteristics must be considered, including Delta(9)-tetrahydrocannabinol (Delta(9)-THC, or THC) concentration, route of administration, dose and frequency, and pharmacokinetics, as well as the risks inherent to particular workplace environments.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 60 条
[1]   Vaporization as a smokeless cannabis delivery system: A pilot study [J].
Abrams, D. I. ;
Vizoso, H. P. ;
Shade, S. B. ;
Jay, C. ;
Kelly, M. E. ;
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :572-578
[2]  
Aggarwal Sunil K, 2007, MedGenMed, V9, P52
[3]  
[Anonymous], 2013, T MED PHYS SOC BENGA
[4]  
[Anonymous], 2013, KIRO NEWS REPORT
[5]  
[Anonymous], 2013, CBS BROADCASTIN 0915
[6]  
[Anonymous], 1982, NEW ENGL J MED, V307, P1280
[7]  
[Anonymous], 2013, INF PHYS MAR
[8]   Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis [J].
Asbridge, Mark ;
Hayden, Jill A. ;
Cartwright, Jennifer L. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[9]  
Baca R, 2014, DENVER POST 0309
[10]   Dose-related neurocognitive effects of marijuana use [J].
Bolla, KI ;
Brown, K ;
Eldreth, D ;
Tate, K ;
Cadet, JL .
NEUROLOGY, 2002, 59 (09) :1337-1343